Paralytic poliomyelitis

Paralytic Poliomyelitis is a severe form of poliomyelitis caused by the poliovirus. This condition leads to the acute onset of flaccid paralysis, often resulting in permanent disability and deformity. Paralytic poliomyelitis primarily affects the motor neurons in the spinal cord and brain stem, leading to muscle weakness and paralysis. The disease can manifest in various forms, including spinal poliomyelitis, bulbar poliomyelitis, and bulbospinal poliomyelitis, each affecting different regions of the central nervous system.

Etiology

Paralytic poliomyelitis is caused by infection with the poliovirus, a member of the Enterovirus genus within the Picornaviridae family. The virus is highly contagious and is transmitted primarily via the fecal-oral route, though it can also spread through oral-oral routes in areas with poor sanitation. Once inside the body, the virus multiplies in the intestine, from where it can invade the central nervous system and cause damage to motor neurons.

Symptoms and Diagnosis

The initial symptoms of paralytic poliomyelitis are similar to those of non-paralytic poliomyelitis and may include fever, headache, vomiting, diarrhea, neck stiffness, and pain in the limbs. However, within a week, individuals with paralytic poliomyelitis develop severe muscle weakness and flaccid paralysis. The diagnosis of paralytic poliomyelitis is primarily clinical but can be confirmed through laboratory tests such as the isolation of poliovirus from stool samples or detection of virus-specific antibodies in the blood.

Treatment and Prevention

There is no cure for paralytic poliomyelitis, and treatment focuses on alleviating symptoms and preventing complications. This may include the use of pain relievers, physical therapy to improve muscle strength and mobility, and ventilators in cases of respiratory muscle paralysis. Prevention of paralytic poliomyelitis is primarily through vaccination with either the inactivated poliovirus vaccine (IPV) or the oral poliovirus vaccine (OPV). Global vaccination efforts have significantly reduced the incidence of paralytic poliomyelitis, leading to the near-eradication of the disease.

Epidemiology

The incidence of paralytic poliomyelitis has decreased dramatically since the introduction of the poliovirus vaccine in the mid-20th century. However, the disease has not been completely eradicated, and cases still occur in a few countries where the virus is endemic or vaccination coverage is incomplete. Children under five years of age are the most susceptible to poliovirus infection and the subsequent development of paralytic poliomyelitis.

Complications

Complications of paralytic poliomyelitis can include permanent muscle weakness, disability, and deformities such as scoliosis and limb length discrepancies. Post-polio syndrome (PPS) is a condition that can occur years after recovery from the initial poliovirus infection, characterized by further weakening of muscles, fatigue, and pain.

Conclusion

Paralytic poliomyelitis is a debilitating disease that can cause permanent disability and death. While there is no cure, vaccination has proven to be an effective means of prevention, leading to a significant decline in the incidence of the disease worldwide. Continued efforts in vaccination and surveillance are essential to achieve the complete eradication of poliovirus.

‎